Abstract
Fungal infections develop slowly in immunocompetent patients and rarely a severe disease, however, they progress rapidly and usually prove fatal in immunocompromised patients. Early diagnosis and treatment of fungal infections is essential to survival of immunocompromised patients. We report a 33-year-old woman with systemic lupus erythematosus undergoing immunotherapy infected with combined invasive pulmonary aspergillosis and pulmonary cryptococcosis diagnosed by video-assisted thoracic surgery lung biopsy and she was successfully treated as a result of early diagnosis and treatment.
MeSH terms
-
Adult
-
Amphotericin B / therapeutic use
-
Antifungal Agents / therapeutic use
-
Aspergillosis / complications*
-
Aspergillosis / drug therapy
-
Cryptococcosis / complications*
-
Cryptococcosis / drug therapy
-
Female
-
Fluconazole / therapeutic use
-
Humans
-
Immunocompromised Host*
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use
-
Lung Diseases, Fungal / complications*
-
Lung Diseases, Fungal / drug therapy
-
Lupus Erythematosus, Systemic / complications
-
Lupus Erythematosus, Systemic / drug therapy
Substances
-
Antifungal Agents
-
Immunosuppressive Agents
-
Amphotericin B
-
Fluconazole